Results 61 to 70 of about 1,525,008 (304)

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future [PDF]

open access: yes, 2019
Ocular diseases cause visual impairment and blindness, imposing a devastating impact on quality of life and a substantial societal economic burden. Many such diseases lack universally effective pharmacotherapies.
Corson, Timothy W., Park, Bomina
core   +1 more source

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

open access: yesCase Reports in Ophthalmology, 2016
Intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents are widely used to treat neovascular age-related macular degeneration (nAMD).
Hisashi Matsubara   +5 more
doaj   +1 more source

Hyperbaric Oxygen Therapy for Recalcitrant Macular Edema Following Branch Retinal Vein Occlusion

open access: yesJournal of Marine Medical Society, 2022
Cystoid macular edema (CME) is the most common cause of reduced vision in branch retinal vein occlusion (BRVO). The treatment protocols for macular edema in BRVO have changed considerably in the previous decade because of the increased popularity of the ...
Avadhesh Oli   +3 more
doaj   +1 more source

Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six months follow-up [PDF]

open access: yes, 2017
AIM: The aim of this study was to compare early and late injections of intravitreal dexamethasone implant in patients affected by central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) with a six-months follow-up.
AUTOLITANO, MONICA   +6 more
core   +1 more source

Repeated intraocular crystallization of ganciclovir in one eye after bilateral intravitreal injections: a case report

open access: yesBMC Ophthalmology, 2018
Background Cytomegalovirus (CMV) retinitis is an opportunistic infection that primarily affects immunocompromised individuals. Intravitreal ganciclovir injection monotherapy or in combination with systemic anti-CMV therapy are effective treatments for ...
Lawrence P. L. Iu   +3 more
doaj   +1 more source

Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion [PDF]

open access: yes, 2016
No abstract ...
Abdolrahimzadeh, Solmaz   +3 more
core   +1 more source

Silicone oil droplets following intravitreal bevacizumab injections

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To report the transient resurgence of symptomatic silicone oil droplets following intravitreal bevacizumab injections. Observations: We report seven patients presenting with silicone oil droplets following intravitreal bevacizumab injections ...
Jea H. Yu   +5 more
doaj   +1 more source

Association of Intravitreal Injections With Blood Pressure Increase: The Following Excitement and Anxiety Response Under Intravitreal Injection Study

open access: yesJAMA ophthalmology, 2019
Importance Despite the unquestionable effectiveness of anti–vascular endothelial growth factor therapy (VEGF), there is ongoing controversy about potential systemic adverse effects.
V. Berger   +5 more
semanticscholar   +1 more source

Hydrodynamics of Intravitreal Injections into Liquid Vitreous Substitutes

open access: yesPharmaceutics, 2019
Intravitreal injections have become the cornerstone of retinal care and one of the most commonly performed procedures across all medical specialties.
C. Henein   +6 more
semanticscholar   +1 more source

Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema [PDF]

open access: yes, 2010
Background: Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema. Methods and Materials: A collective of 32 patients, who had been treated
Al Saeidi, Rashid   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy